Medical device licence · 74602 · Class 2
M.I.C.EVALUATORS
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed August 2, 2007; ended October 19, 2021. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 74602
- Licence holder
- Oxoid LimitedNepean, ON, Canada
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- August 2, 2007
- Ended
- October 19, 2021
- Devices covered
- 23
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- AMIKACIN M.I.C.E.
- AMOXYCILLIN M.I.C.E.
- AMOXYCILLIN/CLAV. ACID M.I.C.E.
- AMPICILLIN M.I.C.E.
- CEFOTAXIME M.I.C.E.
- CEFTAZIDIME 256 M.I.C.E.
- CEFTRIAXONE 32 M.I.C.E.
- CIPROFLOXACIN M.I.C.E.
- CLINDAMYCIN M.I.C.E.
- DAPTOMYCIN M.I.C.E.
- ERYTHROMYCIN M.I.C.E.
- GENTAMICIN M.I.C.E.
- IMIPENEM M.I.C.E.
- LEVOFLOXACIN M.I.C.E.
- LINEZOLID M.I.C.E.
- MEROPENEM 32 M.I.C.E.
- METRONIDAZOLE M.I.C.E.
- OXACILLIN M.I.C.E.
- PENICILLIN M.I.C.E.
- TEICOPLANIN M.I.C.E.
- TETRACYCLINE M.I.C.E.
- TIGECYCLINE M.I.C.E.
- VANCOMYCIN M.I.C.E.
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.